A new study published in Arthritis Care & Research has identified 10 readily available clinical factors that may predict which patients will persistently use high doses of opioids in the year following knee replacement surgery.
In the study of 142,089 Medicare patients with osteoarthritis who underwent total knee replacement surgery and had no history of high-dose opioid use, 10.6% became persistent users of high-dose opioids after surgery.
Certain preoperative characteristics including demographics (age, sex, and race), history of substance abuse (opioids, alcohol, and tobacco), and medication use (benzodiazepines, anxiolytics, antidepressants, anticonvulsants, and nonsteroidal anti-inflammatory drugs) were predictors of persistent use of high-dose opioids after surgery.
“We believe that our prediction model may help identify patients at high risk of future adverse outcomes from persistent opioid use and dependence after total knee replacement surgery,” said senior author Seoyoung C. Kim, MD, ScD, MSCE, of Brigham and Women’s Hospital and Harvard Medical School.
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/10.1002/acr.24559
About Journal
Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals (a division of the College), is a peer-reviewed publication that publishes original research, review articles, and editorials that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with rheumatic diseases, major topics are evidence-based practice studies, clinical problems, practice guidelines, educational, social, and public health issues, health economics, health care policy, and future trends in rheumatology practice.
About Wiley
Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.